Literature DB >> 19591228

Cardiac c-kit+AT2+ cell population is increased in response to ischemic injury and supports cardiomyocyte performance.

Wassim Altarche-Xifró1, Caterina Curato, Elena Kaschina, Aleksandra Grzesiak, Svetlana Slavic, Jun Dong, Kai Kappert, Muscha Steckelings, Hans Imboden, Thomas Unger, Jun Li.   

Abstract

The expression pattern of angiotensin AT2 receptors with predominance during fetal life and upregulation under pathological conditions during tissue injury/repair process suggests that AT2 receptors may exert an important action in injury/repair adaptive mechanisms. Less is known about AT2 receptors in acute ischemia-induced cardiac injury. We aimed here to elucidate the role of AT2 receptors after acute myocardial infarction. Double immunofluorescence staining showed that cardiac AT2 receptors were mainly detected in clusters of small c-kit+ cells accumulating in peri-infarct zone and c-kit+AT2+ cells increased in response to acute cardiac injury. Further, we isolated cardiac c-kit+AT2+ cell population by modified magnetic activated cell sorting and fluorescence activated cell sorting. These cardiac c-kit+AT2+ cells, represented approximately 0.19% of total cardiac cells in infarcted heart, were characterized by upregulated transcription factors implicated in cardiogenic differentiation (Gata-4, Notch-2, Nkx-2.5) and genes required for self-renewal (Tbx-3, c-Myc, Akt). When adult cardiomyocytes and cardiac c-kit+AT2+ cells isolated from infarcted rat hearts were cocultured, AT2 receptor stimulation in vitro inhibited apoptosis of these cocultured cardiomyocytes. Moreover, in vivo AT2 receptor stimulation led to an increased c-kit+AT2+ cell population in the infarcted myocardium and reduced apoptosis of cardiomyocytes in rats with acute myocardial infarction. These data suggest that cardiac c-kit+AT2+ cell population exists and increases after acute ischemic injury. AT2 receptor activation supports performance of cardiomyocytes, thus contributing to cardioprotection via cardiac c-kit+AT2+ cell population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19591228     DOI: 10.1002/stem.171

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  33 in total

1.  Identification and characterization of CD4(+)AT2(+) T lymphocyte population in human thoracic aortic aneurysm.

Authors:  Chenxi Wang; Ting Wu; Xiaojuan Hu; Ritai Huang; Feng Lian; Weijun Wang; Yuan Feng; Bo Xie; Zhenlei Hu; Xinming Zhai; Jidong Liu; Jianmin Gu; Yao Chen; Jun Li; Song Xue
Journal:  Am J Transl Res       Date:  2015-02-15       Impact factor: 4.060

Review 2.  Myocardial AKT: the omnipresent nexus.

Authors:  Mark A Sussman; Mirko Völkers; Kimberlee Fischer; Brandi Bailey; Christopher T Cottage; Shabana Din; Natalie Gude; Daniele Avitabile; Roberto Alvarez; Balaji Sundararaman; Pearl Quijada; Matt Mason; Mathias H Konstandin; Amy Malhowski; Zhaokang Cheng; Mohsin Khan; Michael McGregor
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

3.  Perspective: A tale of two receptors.

Authors:  Sébastien Foulquier; Ulrike Muscha Steckelings; Thomas Unger
Journal:  Nature       Date:  2013-01-31       Impact factor: 49.962

Review 4.  AT2 receptors targeting cardiac protection post-myocardial infarction.

Authors:  Elena Kaschina; Dilyara Lauer; Patrick Schmerler; Thomas Unger; U Muscha Steckelings
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

5.  Mice lacking angiotensin type 2 receptor exhibit a sex-specific attenuation of insulin sensitivity.

Authors:  Diego T Quiroga; Johanna G Miquet; Lorena Gonzalez; Ana I Sotelo; Marina C Muñoz; Pedro M Geraldes; Jorge F Giani; Fernando P Dominici
Journal:  Mol Cell Endocrinol       Date:  2019-09-17       Impact factor: 4.102

Review 6.  Emerging Role of Angiotensin AT2 Receptor in Anti-Inflammation: An Update.

Authors:  Sanket N Patel; Naureen Fatima; Riyasat Ali; Tahir Hussain
Journal:  Curr Pharm Des       Date:  2020       Impact factor: 3.116

7.  Chronic AMD3100 antagonism of SDF-1alpha-CXCR4 exacerbates cardiac dysfunction and remodeling after myocardial infarction.

Authors:  Shujing Dai; Fangping Yuan; Jingyao Mu; Chengxin Li; Ning Chen; Shangzhi Guo; Justin Kingery; Sumanth D Prabhu; Roberto Bolli; Gregg Rokosh
Journal:  J Mol Cell Cardiol       Date:  2010-07-23       Impact factor: 5.000

8.  TNF, acting through inducibly expressed TNFR2, drives activation and cell cycle entry of c-Kit+ cardiac stem cells in ischemic heart disease.

Authors:  Rafia S Al-Lamki; Wanhua Lu; Jun Wang; Jun Yang; Timothy J Sargeant; Richard Wells; Chenqu Suo; Penny Wright; Martin Goddard; Qunhua Huang; Amir H Lebastchi; George Tellides; Yingqun Huang; Wang Min; Jordan S Pober; John R Bradley
Journal:  Stem Cells       Date:  2013-09       Impact factor: 6.277

9.  Sphingosine 1-phosphate elicits RhoA-dependent proliferation and MRTF-A mediated gene induction in CPCs.

Authors:  Alessandra Castaldi; Gino P Chesini; Amy E Taylor; Mark A Sussman; Joan Heller Brown; Nicole H Purcell
Journal:  Cell Signal       Date:  2016-04-14       Impact factor: 4.315

Review 10.  Impact of the AT(2) receptor agonist C21 on blood pressure and beyond.

Authors:  Sébastien Foulquier; U Muscha Steckelings; Thomas Unger
Journal:  Curr Hypertens Rep       Date:  2012-10       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.